Reference information only. Always consult a qualified healthcare professional.
MPMediPriceHubMedicine price reference
PRODUCT INFORMATION

Calciumfolinat Kabi 10mg/ml Infusionsl sung,10 x 10ml (Calcium Folinate)

Calcium Folinate

Calciumfolinat Kabi 10mg/ml Infusionsl sung,10 x 10ml (Calcium Folinate)
Reference priceUSD $630.00Original source price: INR 52,500.00. Converted estimates are available by currency selection.
BrandCalciumfolinat Kabi
ManufacturerFresenius Kabi Deutschland GmbH
Prescription requiredYes

Description

Calciumfolinat Kabi 10mg/ml Infusionsl sung,10 x 10ml (Calcium Folinate) is a medicine catalog record in the MediPriceHub database. Active ingredient: Calcium Folinate. Clinical use summary: See the Benefits field on this page for the product-specific indication or intended use. That field is kept separate from catalog metadata so users can distinguish clinical information from packaging information. Manufacturer or supplier: Fresenius Kabi Deutschland GmbH. Therapeutic category: Medicine Library > Oncology Medicines > Colorectal Cancer Medicines. Pack information: 10 / 100, 10 x 10. Origin country or market: Germany. This page is for medicine catalog reference only and should be read together with the approved prescribing information in the patient or buyer's country.

Benefits

Atorvastatin Calcium Tablets are indicated: To reduce the risk of: Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD As an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in: Adults with primary hyperlipidemia. Adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). As an adjunct to other LDL-C-lowering therapies, or alone if such treatments are unavailable, to reduce LDL-C in adults and pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia (HoFH). As an adjunct to diet for the treatment of adults with: Primary dysbetalipoproteinemia Hypertriglyceridemia

How to Use

Use Calcium Folinate under the supervision of a qualified healthcare professional. It should be prepared and administered only by trained healthcare professionals in a setting appropriate for injectable or infusion medicines. Do not start, stop, change the dose, split or crush a dosage form, mix with other medicines, or repeat a course unless the approved product information or a clinician confirms that it is appropriate. Check the local prescribing information for age limits, dose adjustments, missed-dose instructions, storage after opening or reconstitution, and monitoring requirements.

Specification

Active ingredient: Calcium Folinate. Pack size: 10 / 100, 10 x 10. Pack unit: box. Manufacturer: Fresenius Kabi Deutschland GmbH. Origin country: Germany. Source category: Medicine Library > Oncology Medicines > Colorectal Cancer Medicines. Availability, prescription status, storage, and exact approved use may vary by country. Check the local product information before clinical or procurement decisions.

Side Effects

Cancer medicines may cause fatigue, nausea, vomiting, diarrhea or constipation, appetite changes, mouth sores, rash, changes in blood counts, infection risk, liver or kidney test changes, bleeding risk, neuropathy, infusion reactions, or organ-specific toxicity depending on the medicine. Injectable and infusion products may also cause administration-site pain, swelling, infection, infusion reactions, or hypersensitivity. Seek urgent medical care for severe allergic symptoms, breathing difficulty, fainting, severe skin reactions, chest pain, confusion, serious bleeding, signs of infection, or rapidly worsening symptoms. The approved local prescribing information is the controlling source for the complete adverse-reaction profile.

This information is for reference only. Consult a qualified healthcare professional before using any medicine.